Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.

MicroRNA-182 promotes tumor cell growth by targeting transcription elongation factor A-like 7 in endometrial carcinoma.

Guo Y, Liao Y, Jia C, Ren J, Wang J, Li T.

Cell Physiol Biochem. 2013;32(3):581-90. doi: 10.1159/000354462. Epub 2013 Sep 6.

2.

MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.

Xu YY, Wu HJ, Ma HD, Xu LP, Huo Y, Yin LR.

FEBS J. 2013 Aug;280(16):3768-79. doi: 10.1111/febs.12365. Epub 2013 Jun 27.

3.

microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1.

Zhou H, Xu X, Xun Q, Yu D, Ling J, Guo F, Yan Y, Shi J, Hu Y.

Oncol Rep. 2012 Mar;27(3):807-12. doi: 10.3892/or.2011.1574. Epub 2011 Dec 1.

PMID:
22139444
4.

TCEAL7, a putative tumor suppressor gene, negatively regulates NF-kappaB pathway.

Rattan R, Narita K, Chien J, Maguire JL, Shridhar R, Giri S, Shridhar V.

Oncogene. 2010 Mar 4;29(9):1362-73. doi: 10.1038/onc.2009.431. Epub 2009 Dec 7.

PMID:
19966855
5.

MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo.

Jiang F, Liu T, He Y, Yan Q, Chen X, Wang H, Wan X.

BMC Cancer. 2011 Oct 5;11:425. doi: 10.1186/1471-2407-11-425.

6.

Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.

Rivas MA, Venturutti L, Huang YW, Schillaci R, Huang TH, Elizalde PV.

Breast Cancer Res. 2012 May 14;14(3):R77.

7.

MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.

Chen S, Sun KX, Liu BL, Zong ZH, Zhao Y.

Mol Cancer. 2016 Feb 2;15:11. doi: 10.1186/s12943-016-0496-4.

8.

The expression of S100P increases and promotes cellular proliferation by increasing nuclear translocation of β-catenin in endometrial cancer.

Guo L, Chen S, Jiang H, Huang J, Jin W, Yao S.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2102-12. eCollection 2014.

9.

Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathway.

Tang ZP, Dong QZ, Cui QZ, Papavassiliou P, Wang ED, Wang EH.

PLoS One. 2013 Jun 12;8(6):e63676. doi: 10.1371/journal.pone.0063676. Print 2013.

10.

A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation.

Chien J, Narita K, Rattan R, Giri S, Shridhar R, Staub J, Beleford D, Lai J, Roberts LR, Molina J, Kaufmann SH, Prendergast GC, Shridhar V.

Oncogene. 2008 Dec 11;27(58):7223-34. doi: 10.1038/onc.2008.360. Epub 2008 Sep 22.

11.

miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.

Li HP, Zeng XC, Zhang B, Long JT, Zhou B, Tan GS, Zeng WX, Chen W, Yang JY.

Carcinogenesis. 2013 Nov;34(11):2443-51. doi: 10.1093/carcin/bgt206. Epub 2013 Jun 5.

PMID:
23740840
12.

The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression.

Sun KX, Chen Y, Chen S, Liu BL, Feng MX, Zong ZH, Zhao Y.

Oncotarget. 2016 Feb 23;7(8):9236-49. doi: 10.18632/oncotarget.7061.

13.

[Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].

Zhang G, Li XP, Wang JL, Wei LH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):839-45. Chinese.

PMID:
23302125
14.

miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc.

He W, Li Y, Chen X, Lu L, Tang B, Wang Z, Pan Y, Cai S, He Y, Ke Z.

J Gastroenterol Hepatol. 2014;29(7):1427-34. doi: 10.1111/jgh.12558.

PMID:
24612089
15.

MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2.

Shang C, Lu YM, Meng LR.

Med Sci Monit. 2012 Apr;18(4):BR149-55.

16.

Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line.

Biliran H Jr, Wang Y, Banerjee S, Xu H, Heng H, Thakur A, Bollig A, Sarkar FH, Liao JD.

Clin Cancer Res. 2005 Aug 15;11(16):6075-86.

17.

Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.

Xiong J, Du Q, Liang Z.

Oncogene. 2010 Sep 2;29(35):4980-8. doi: 10.1038/onc.2010.241. Epub 2010 Jun 21.

PMID:
20562918
18.

Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.

Wu Z, He B, He J, Mao X.

Prostate. 2013 May;73(6):596-604. doi: 10.1002/pros.22600. Epub 2012 Oct 11.

PMID:
23060044
19.

Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling.

Zhang Y, Wei W, Cheng N, Wang K, Li B, Jiang X, Sun S.

Hepatology. 2012 Nov;56(5):1631-40. doi: 10.1002/hep.25849. Epub 2012 Oct 9.

PMID:
22610915
20.

Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs.

Shu J, Xia Z, Li L, Liang ET, Slipek N, Shen D, Foo J, Subramanian S, Steer CJ.

RNA Biol. 2012 Oct;9(10):1275-87. doi: 10.4161/rna.21998. Epub 2012 Sep 20.

Supplemental Content

Support Center